UCSB researchers report a method for prolonging blood circulation of nanoparticles for potential applications in drug delivery
The research team, led by Samir Mitragotri, a professor of chemical engineering, and Elizabeth Chambers, a recent doctoral graduate, found that nanoparticles can be forced to remain in circulation when attached to red blood cells. The particles eventually detach from the blood cells due to shear forces and cell-to-cell interactions, and are cleared from the system by the liver and spleen. Red blood cell circulation is not affected by attaching the nanoparticles.
“Attachment of polymeric nanoparticles to red blood cells combines the advantages of the long circulating lifetime of the red blood cell, and their abundance, with the robustness of polymeric nanoparticles,” said Mitragotri. “Using red blood cells to extend the circulation time of the particles avoids the need to modify the surface chemistry of the entire particle, which offers the potential to attach chemicals to the exposed surface for targeting applications.”
The researchers have learned that particles adhered to red blood cells can escape phagocytosis because red blood cells have a knack for evading macrophages. Nanoparticles aren’t the first to be piggybacking on red blood cells; the strategy has already been adopted by certain bacteria, such as hemobartonella, that adhere to RBCs and can remain in circulation for several weeks.
The researchers say that it may be possible to keep the nanoparticles in circulation for a relatively long time, theoretically up to the circulation lifetime of a red blood cell – which is 120 days – if the binding between particles and the red blood cells is strengthened. The methodology is applicable to drugs that are effective while still attached to a red blood cell, although the researchers say that slow release from the red blood cell surface is also feasible.
Mitragotri says this mode of prolonging particle circulation has significant implications in drug delivery, potentially leading to new treatments for a broad variety of conditions such as cancer, blood clots and heart disease. ###
The research was supported by the Institute of Collaborative Biotechnologies and the National Institutes of Health, Program of Excellence in Nanotechnology.
Contact: Barbara B. Gray bbgray@engineering.ucsb.edu 818-889-5415, Samir Mitragotri 805-893-7532 samir@engine, Web: University of California - Santa Barbara
Technorati Tags: Nano or Nanotechnology and Nanotech and polymeric nanoparticles or Red blood cell and University of California - Santa Barbara or phagocytosis and hemobartonella and Pairing Nanoparticles with Proteins or Famous People Mark Twain (Samuel Langhorne Clemens) and Happy Birthday President Bush
No comments:
Post a Comment